• No results found

Vasoactive intestinal peptide (VIP)

The action of vasoactive intestinal peptide antagonists on peptidergic modulation of the squid Schwann cell

The action of vasoactive intestinal peptide antagonists on peptidergic modulation of the squid Schwann cell

... The effects of two specific antagonists of vasoactive intestinal peptide VIP receptors were investigated on the VIP-induced hyperpolarization of the membrane potential of the Schwann cel[r] ...

12

Treatment of Acute Respiratory Distress Syndrome with Vasoactive Intestinal Peptide

Treatment of Acute Respiratory Distress Syndrome with Vasoactive Intestinal Peptide

... In March 2020, the US Food and Drug Administration cleared the investigational use of RLF-100 (aviptadil: a synthetic form of Vasoactive Intestinal Peptide (VIP)) for the treatment of Critical ...

11

Actin reorganization is involved in vasoactive intestinal peptide induced human mast cells priming to fraktalkine-induced chemotaxis

Actin reorganization is involved in vasoactive intestinal peptide induced human mast cells priming to fraktalkine-induced chemotaxis

... between vasoactive intestinal peptide (VIP) and fraktalkine (FKN) in recruiting human mast cells to the asthmatic airway that provided a classical example of priming effect on mast cells ...

6

Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout

Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout

... and vasoactive intestinal peptide (VIP) belong to the secretin–glucagon superfamily of peptides (Sherwood et ...acid peptide (PACAP-38) and the C- terminally truncated 27 amino acid ...

9

Vasoactive intestinal peptide in human nasal mucosa

Vasoactive intestinal peptide in human nasal mucosa

... Vasoactive intestinal peptide (VIP), which is present with acetylcholine in parasympathetic nerve fibers, may have important regulatory functions in mucous ...for VIP in human nasal ...

8

Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension

Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension

... the vasoactive intestinal peptide (VIP) shows striking pharmacological characteristics that might be worthy of testing for its ability in combating ...that VIP may play a role in the ...

9

Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats

Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats

... lipophilic vasoactive intestinal peptide (VIP) analogue unable to cross the BBB (Gozes et ...1996). VIP is a 28-amino acid neuropeptide of the glucagon-secretin family (Mutt and Said, ...

11

Role of vasoactive intestinal peptide in osteoarthritis

Role of vasoactive intestinal peptide in osteoarthritis

... Vasoactive intestinal peptide (VIP) plays important roles in many biological functions, such as, stimulation of contractility in the heart, vasodilation, promoting neuroendocrine-immune ...

6

Vasoactive Intestinal Peptide (VIP) and VIP Receptors Elucidation of Structure and Function for Therapeutic Applications

Vasoactive Intestinal Peptide (VIP) and VIP Receptors Elucidation of Structure and Function for Therapeutic Applications

... Vasoactive intestinal peptide (VIP) is a 28-amino acid polypeptide that was first isolated from swine duodenum about 40 years ...the intestinal blood flow [1]. VIP was first ...

9

Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain

Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain

... The vasoactive intestinal peptide (VIP) is a 28-amino acid neuropeptide of the glucagon-secretin family (Mutt and Said, 1970) with a widespread distri- bution in both the central and ...

9

Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent

Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent

... Vasoactive intestinal peptide (VIP) has been shown to regu- late early postimplantation growth in rodents through cen- tral nervous system ...of VIP mediating these effects is unknown. ...

8

Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity dependent neurotrophic factor

Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity dependent neurotrophic factor

... rats. Vasoactive intestinal peptide, a neuropeptide regulator of early post- implantation embryonic growth, and the neuroprotective protein, activity-dependent neurotrophic factor, prevent ...

6

Vasoactive Intestinal Peptide Stimulation of Adenylate Cyclase and Active Electrolyte Secretion in Intestinal Mucosa

Vasoactive Intestinal Peptide Stimulation of Adenylate Cyclase and Active Electrolyte Secretion in Intestinal Mucosa

... mucosa, VIP (20 µg/ml) caused a prompt fivefold increase in cyclic AMP level, whereas nine other hormones, which have been postulated to cause intestinal secretion, failed to exert such an ...a VIP ...

10

Importance of the Vasoactive Intestinal Peptide Receptor in the Stimulation of Cyclic Adenosine 3′,5′ Monophosphate in Gallbladder Epithelial Cells of Man: COMPARISON WITH THE GUINEA PIG

Importance of the Vasoactive Intestinal Peptide Receptor in the Stimulation of Cyclic Adenosine 3′,5′ Monophosphate in Gallbladder Epithelial Cells of Man: COMPARISON WITH THE GUINEA PIG

... for VIP were characterized in these ...I-labeled VIP reached a peak within 20 min and then declined ...labeled peptide was inhibited by concentrations of native VIP of 30 ...

12

Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens

Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens

... of VIP in this experiment, the full pharmacological effect of VIP may not have been observed; the P100 latency and amp- litude in the VIP intervention group remained signifi- cantly different from ...

9

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review

... of VIP binding sites were found in the pulmonary vascular smooth muscle layer and in airway smooth muscle of large, but not smaller ...airways. VIP binding sites are also present in sub-mucosal glands, air- ...

8

Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro

Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro

... the VIP antago- nist, together with 1 nM VIP, was very close to the shape of the dose-response curve obtained with increasing concentrations of VIP alone, except that the amplitude of the response ...

12

Intractable Diarrhea in a Boy With Vasoactive Intestinal Peptide-Producing Ganglioneuroblastoma

Intractable Diarrhea in a Boy With Vasoactive Intestinal Peptide-Producing Ganglioneuroblastoma

... In most patients with a neural crest tumor and chronic diarrhea, urinary catecholamine levels.. were also shown to be elevated.’72 These.[r] ...

9

Localization and function of VIP and PACAP in the heart

Localization and function of VIP and PACAP in the heart

... Vasoactive intestinal peptide (VIP) is a linear 28-amino-acid peptide with molecular weight of 3,326 Da that is generated by enzymatic cleavage from its precursor molecule, ...of ...

6

Vasoactive intestinal peptide (VIP) differentially affects inflammatory immune responses in human monocytes infected with viable Salmonella or stimulated with LPS

Vasoactive intestinal peptide (VIP) differentially affects inflammatory immune responses in human monocytes infected with viable Salmonella or stimulated with LPS

... increased apoptosis of blood monocytes and increased survival of sepsis patients has been.. previously reported 24 and elevated monocyte numbers has also been reported to correlate.[r] ...

28

Show all 8888 documents...

Related subjects